Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy

Australas J Dermatol. 2022 May;63(2):235-239. doi: 10.1111/ajd.13838. Epub 2022 Apr 12.

Abstract

Facial capillary malformations (CMs) become hypertrophic and nodular overtime and pose great therapeutic challenge. Here, we describe safe and effective use of tumescent-assisted sclerotherapy (TAS) in conjunction with yellow vascular laser (577 nm) for the treatment of HFCMs. Three patients underwent TAS were included in the case series, and complete resolution in nodularity was achieved in all patients with TAS, with no major complications such as skin necrosis, distal embolisation, blindness and neurological adverse events such as stroke or TIA occurred in any patients.

Keywords: CM; Capillary malformation; facial vascular malformation; sclerotherapy; tumescent anaesthesia.

MeSH terms

  • Capillaries / abnormalities
  • Face
  • Humans
  • Hypertrophy / etiology
  • Hypertrophy / therapy
  • Retrospective Studies
  • Sclerotherapy* / adverse effects
  • Treatment Outcome
  • Vascular Malformations* / etiology
  • Vascular Malformations* / therapy

Supplementary concepts

  • Capillary Malformations, Congenital, 1